A Multiple Ascending Dose Study of MEDI7247 in Patients With Selected Relapsed/Refractory Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
A Safety Study of Lenalidomide in Previously Untreated Adult Multiple Myeloma Patients Who Are Not Eligible for Transplant
- Status
- COMPLETED
- Phase
- N/A
Evaluation iNduction, Consolidation and Maintenance Treatment With Isatuximab , Carfilzomib, LEnalidomide and Dexamethasone
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Combination Study for High Risk Multiple Myeloma Patients
- Status
- TERMINATED
- Phase
- PHASE2
BCMA Chimeric Antigen Receptor Expressing T Cells in Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE1
A Study of Dabrafenib and/or Trametinib in Patients With Relapsed and/or Refractory Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Real-world Use of Carfilzomib Among Multiple Myeloma Patients in Europe
- Status
- COMPLETED
- Phase
- N/A
BCMA Targeted CAR T Cells With or Without Lenalidomide for the Treatment of Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Integrating Touchscreen-based Geriatric Assessment and Frailty Screening for Adults With Multiple Myeloma
- Status
- COMPLETED
- Phase
- NA
Study of Bromodomain and Extra-Terminal Protein (BET) Inhibitor RO6870810 as Mono- and Combination Therapy in Advanced Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Assessing the Clinical Benefit of Molecular Profiling in Patients With Solid Tumors
- Status
- TERMINATED
- Phase
- N/A
Improving the Quality of Multiple Myeloma Treatment With Patient Care Plans
- Status
- COMPLETED
- Phase
- NA
Vaccination With PD-L1 Peptide Against Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
A Evaluation of the Safety of Oncocort IV Pegylated Liposomal Dexamethasone Phosphate in Patients With Progressive Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Nivolumab Role in the Treatment of Patients With Refractory or Relapse Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1
Ph I Trial of NAM NK Cells and IL-2 for Adult Pts With MM and NHL
- Status
- COMPLETED
- Phase
- PHASE1
Calcineurin Inhibitor-Free GVHD Prevention Regimen After Related Haplo PBSCT
- Status
- COMPLETED
- Phase
- PHASE1
Umbilical Cord Blood Transplantation From Unrelated Donors
- Status
- RECRUITING
- Phase
- N/A
Viral Immunotherapy in Relapsed/Refractory Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE1
Mobile Health Device Study for Myeloma Patients
- Status
- COMPLETED
- Phase
- N/A